✦ LIBER ✦

Aquaretic and hormonal effects of a vasopressin V2 receptor antagonist after acute and long-term treatment in rats

✍ Scribed by Colette Lacour; Gérard Galindo; Françoise Canals; Danielle Segondy; Catherine Cazaubon; Claudine Serradeil-Le Gal; Alain Roccon; Dino Nisato

Book ID: 114012866
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 259 KB
Volume: 394
Category: Article
ISSN: 0014-2999
DOI: 10.1016/s0014-2999(00)00088-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of long-term oral treatment with

Effects of long-term oral treatment with selective vasopressin V2 receptor antagonist (OPC-31260) on adriamycin-induced heart failure in rats

✍ Masayuki Takeuchi; Jong-Dae Lee; Hiromasa Shimizu; Takanori Ueda 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Sustained aquaretic effect of the V2-AVP

Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention

✍ Josefa Ros; Guillermo Fernández-Varo; Javier Muñoz-Luque; Vicente Arroyo; Juan R 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 177 KB

Acute hemodynamic effects of conivaptan,

Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure

✍ J.E. Udelson; W.B. Smith; G.H. Hendrix 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB

102 EFFECTS OF SATAVAPTAN, AN ORAL VASOP

102 EFFECTS OF SATAVAPTAN, AN ORAL VASOPRESSIN V2 RECEPTOR ANTAGONIST, ON MANAGEMENT OF ASCITES AND MORBIDITY IN LIVER CIRRHOSIS IN A LONG-TERM, PLACEBO-CONTROLLED STUDY

✍ F. Wong; M. Bernardi; Y. Horsmans; Z. Cabrijan; H. Watson; P. Gines 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

EFFECT OF CONIVAPTAN, A COMBINED VASOPRE

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V1a AND V2 RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

✍ TAKEYUKI YATSU; TOSHIYUKI KUSAYAMA; YUICHI TOMURA; YUKINORI ARAI; MOTONORI AOKI; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Pharmacokinetic and pharmacodynamic effe

Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2vasopressin receptor antagonist in normal subjects

✍ M. Burnier; A. F. Fricker; D. Hayoz; J. Nussberger; H. R. Brunner 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 110 KB